MedTrace Logo

Engaging Men Through HIV Self-Testing With Differentiated Care to Improve ART Initiation and Viral Suppression Among Men in Malawi

NCT04858243 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 930

Last updated 2023-05-15

No results posted yet for this study

Summary

Men in sub-Saharan Africa who test HIV-positive continue to have poor ART initiation and retention outcomes. The proposed project will test a home-based ART intervention for men who are living with HIV compared to facility-based ART. Findings will provide essential information on how to best reach men across the testing and treatment continuum, a critical step to curbing the HIV epidemic.

Conditions

Interventions

OTHER

Home-Based ART

Community-based male-specific counseling followed by home-based ART initiation (or at any location that is convenient for participants) and home-based ART continuation for a 3-month period, followed by linkage to a local health facility for further ART continuation.

OTHER

Facility-Based ART

Community-based male-specific counseling followed by linkage to a local health facility for ART initiation and continuation.

Sponsors & Collaborators

  • Partners in Hope, Inc.

    collaborator INDUSTRY

  • Medical University of South Carolina

    collaborator OTHER

  • Charles University, Czech Republic

    collaborator OTHER

  • University of Cape Town

    collaborator OTHER

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • University of California, Los Angeles

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-08-02
Primary Completion
2025-03-31
Completion
2025-06-30

Countries

  • Malawi

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04858243 on ClinicalTrials.gov